tiprankstipranks
Trending News
More News >
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market

Werewolf Therapeutics (HOWL) Financial Statements

Compare
776 Followers

Werewolf Therapeutics Financial Overview

Werewolf Therapeutics's market cap is currently $28.36M. The company's EPS TTM is $-0.36; its P/E ratio is -0.34; Werewolf Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.89M$ 19.94M$ 16.40M$ 0.00$ 0.00
Gross Profit$ 71.00K$ 18.18M$ 13.89M$ 0.00$ -777.00K
Operating Income$ -73.59M$ -40.50M$ -56.06M$ -50.09M$ -22.40M
EBITDA$ -64.05M$ -32.47M$ -51.30M$ -49.87M$ -14.26M
Net Income$ -70.52M$ -37.37M$ -53.81M$ -49.98M$ -14.94M
Balance Sheet
Cash & Short-Term Investments$ 111.00M$ 134.34M$ 129.31M$ 157.53M$ 92.57M
Total Assets$ 126.93M$ 174.83M$ 160.25M$ 179.25M$ 96.40M
Total Debt$ 37.09M$ 51.92M$ 14.68M$ 15.66M$ 2.54M
Net Debt$ -73.91M$ -82.42M$ -114.63M$ -141.87M$ -90.03M
Total Liabilities$ 53.54M$ 63.46M$ 37.91M$ 26.46M$ 7.18M
Stockholders' Equity$ 73.39M$ 111.37M$ 122.34M$ 152.79M$ 89.22M
Cash Flow
Free Cash Flow$ -56.44M$ -33.38M$ -44.21M$ -43.37M$ -19.18M
Operating Cash Flow$ -56.19M$ -32.61M$ -40.60M$ -42.88M$ -18.62M
Investing Cash Flow$ -254.00K$ -769.00K$ -3.61M$ -498.00K$ -560.00K
Financing Cash Flow$ 13.08M$ 58.43M$ 15.91M$ 109.43M$ 93.86M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Werewolf Therapeutics Debt to Assets

Werewolf Therapeutics Cash Flow

Werewolf Therapeutics Forecast EPS vs Actual EPS